tiprankstipranks
Trending News
More News >
COSCIENS Biopharma (TSE:CSCI)
TSX:CSCI

COSCIENS Biopharma (CSCI) Revenue

Compare
40 Followers

COSCIENS Biopharma Revenue

COSCIENS Biopharma had a revenue of 2.34M in the quarter ending Jun 30, 2024, with 58325.00%. This bring the company's revenue in the last twelve months to 2.46M, Decreased 3.83%. In the fiscal year ending Dec 31, 2023, COSCIENS Biopharma had annual revenue of 4.50M with -20.25% growth.
Revenue (ttm)
2.46M
Revenue Growth
P/S Ratio
2.03
Revenue/Employee
C$112,450
Employees
40
Market Cap
C$9.14M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023
4.50M-1.14M+79.75%
Dec 31, 2022
5.64M380.00K+107.22%
Dec 31, 2021
5.26M1.61M+144.03%
Dec 31, 2020
3.65M3.12M+686.47%
Dec 31, 2019
532.00K-26.35M+1.98%
Dec 31, 2018
26.88M25.96M+2,912.35%
Dec 31, 2017
923.00K